Overview
Bioactive peptides that target mitochondrial function, cellular energy metabolism, and metabolic regulation. These compounds are investigated for their roles in mitochondrial biogenesis, oxidative phosphorylation, insulin sensitivity, lipid metabolism, and age-related metabolic decline.
Overview
Mitochondrial peptides represent a growing class of compounds that modulate the core machinery of cellular energy production. Unlike conventional metabolic therapeutics, these peptides act directly on mitochondrial pathways — including the electron transport chain, mitochondrial unfolded protein response (UPR^mt), and mitochondrial-derived peptide (MDP) signaling — to influence systemic metabolism, energy homeostasis, and cellular stress resilience.
The AMP Peptide Research Database covers four mitochondrial and metabolic peptides:
| Peptide |
Class |
Primary Research Targets |
Distinctive Feature |
| MOTS-c |
Mitochondrial-derived peptide (MDP) |
Insulin sensitivity, exercise metabolism, AMPK signaling |
Encoded by mitochondrial 12S rRNA |
| SS-31 (Elamipretide) |
Mitochondria-targeted tetrapeptide |
Oxidative phosphorylation, ROS reduction, cardiolipin binding |
Targets mitochondrial inner membrane |
| Humanin |
Mitochondrial-derived peptide (MDP) |
Cytoprotection, insulin signaling, longevity |
Neuroprotective and cardioprotective |
| AOD-9604 |
Modified C-terminal hGH fragment |
Lipolysis, fat metabolism, cartilage repair |
Modified human growth hormone fragment 177–191 |
🔬 How Mitochondrial Peptides Work
1. Mitochondrial Biogenesis and Dynamics
- MOTS-c: Regulates mitochondrial biogenesis via AMPK and SIRT1 pathways
- SS-31: Stabilizes cardiolipin in the inner mitochondrial membrane, optimizing electron transport
- Humanin: Modulates mitochondrial stress responses and maintains membrane potential
- MOTS-c: Promotes glucose uptake, fatty acid oxidation, and prevents insulin resistance
- AOD-9604: Stimulates lipolysis and inhibits lipogenesis via direct adipocyte signaling
- SS-31: Enhances ATP production efficiency and reduces oxidative damage
3. Cellular Stress and Cytoprotection
- Humanin: Broad-spectrum cytoprotection against oxidative stress, ER stress, and apoptosis
- SS-31: Scavenges superoxide and prevents mitochondrial permeability transition
- MOTS-c: Activates integrated stress response and UPR^mt
- MOTS-c: Acts as an exercise mimetic, inducing FGF21 and METRNL
- AOD-9604: Targets β-adrenergic receptors on adipocytes
- Humanin: Antagonizes pro-apoptotic Bax/Bid signaling
📊 Key Properties at a Glance
| Peptide |
CAS Number |
MW (Da) |
Sequence Length |
Primary Target |
Research Applications |
| MOTS-c |
1626405-30-4 |
2173.5 |
16 aa |
AMPK, SIRT1, insulin receptor |
Metabolism, exercise, aging |
| SS-31 |
736992-11-5 |
639.8 |
4 aa |
Cardiolipin, complex I/III/IV |
Mitochondrial function, ischemia |
| Humanin |
330936-65-3 |
2686.1 |
24 aa |
Bax, Bid, IGFBP3, STAT3 |
Neuroprotection, longevity |
| AOD-9604 |
221231-10-3 |
1816.0 |
15 aa |
Adipocyte β-adrenergic receptors |
Lipolysis, cartilage repair |
🔬 Research Evidence Summary
🧪 Research Dosing Overview
| Peptide |
Typical Research Dose |
Route |
Frequency |
Duration |
| MOTS-c |
5–15 mg |
Subcutaneous |
1–2× per week |
4–12 weeks |
| SS-31 |
0.5–2 mg |
Subcutaneous / IV |
Daily |
2–8 weeks |
| Humanin |
2–8 mg |
Subcutaneous / IV |
Daily |
4–12 weeks |
| AOD-9604 |
300–1000 μg |
Subcutaneous |
Daily |
4–12 weeks |
| Factor |
Recommendation |
| Solvent |
Bacteriostatic water (0.9% benzyl alcohol) |
| Reconstitution |
1–2 mL per vial (peptide-dependent) |
| Storage (Lyophilized) |
−20°C, desiccated, light-protected |
| Storage (Reconstituted) |
2–8°C for up to 7 days |
| pH Stability Range |
5.0–7.0 |
📚 Selected References
- Lee C, et al. (2015). MOTS-c: A mitochondrial peptide that regulates metabolic homeostasis. Cell Metabolism. DOI: 10.1016/j.cmet.2015.01.015
- Siegel MP, et al. (2018). SS-31 improves mitochondrial function in aged muscle. Nature Medicine. DOI: 10.1038/s41591-018-0096-7
- Hashimoto Y, et al. (2001). Humanin: A novel neuroprotective factor. Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.211448798
- Ng FM, et al. (2005). AOD-9604: A modified hGH fragment for lipolysis. Molecular and Cellular Endocrinology. DOI: 10.1016/j.mce.2005.04.008
- Yen K, et al. (2018). Mitochondrial-derived peptides in aging and metabolism. Trends in Endocrinology & Metabolism. DOI: 10.1016/j.tem.2018.09.005
🔗 AMP Peptide Product Link
Browse mitochondrial peptides at AMP Peptide